Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria

Malaria afflicts around 200 million people annually, with a mortality number close to 600,000. The mortality rate in Human Cerebral Malaria (HCM) is unacceptably high (15–20%), despite the availability of artemisinin-based therapy. An effective adjunct therapy is urgently needed. Experimental Cerebr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dende, Chaitanya, Meena, Jairam, Nagarajan, Perumal, Panda, Amulya K., Rangarajan, Pundi N., Padmanaban, Govindarajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521148/
https://www.ncbi.nlm.nih.gov/pubmed/26227888
http://dx.doi.org/10.1038/srep12671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521148/
https://www.ncbi.nlm.nih.gov/pubmed/26227888
http://dx.doi.org/10.1038/srep12671

Ejemplares similares